Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Graft vs Host Disease 1

Interventions

Tacrolimus 8Methotrexate 7Cyclophosphamide 7Mycophenolic Acid 6Sirolimus 5Busulfan 5fludarabine phosphate 4fludarabine 4Peripheral Blood Stem Cell Transplantation 4Melphalan 3Cyclosporine 3thymoglobulin 2ibrutinib 2Whole-Body Irradiation 2Vorinostat 2Filgrastim 2Antilymphocyte Serum 2plerixafor 1carfilzomib 1aldesleukin 1Transplantation Conditioning 1Thiotepa 1Pentostatin 1Mesna 1Leukocyte Count 1KRN 7000 1Hematopoietic Stem Cell Transplantation 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Graft vs Host Disease × Leukocyte Count × Clear all
NCT00900497 2026-05-01

A Study Using White Blood Cells From Healthy Donors To Treat Solid Cancers

South Florida Bone Marrow/Stem Cell Transplant Institute

Phase 1/2 Enrolling by invitation
29 enrolled

Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡